Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-01-10 @ 4:17 AM
Study NCT ID:
NCT05515120
Status:
COMPLETED
Last Update Posted:
2022-08-25
First Post:
2022-08-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
Sponsor:
Instituto Mexicano del Seguro Social
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-03
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-18
First Submit QC Date:
None
Study First Post Date:
2022-08-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-24
Last Update Post Date:
2022-08-25
Last Update Post Date Type:
ACTUAL